We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cancer Genetics, Icon Partner
News

Cancer Genetics, Icon Partner

Cancer Genetics, Icon Partner
News

Cancer Genetics, Icon Partner

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Cancer Genetics, Icon Partner "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The partners will provide services from complex oncology genomic testing to core central laboratory analysis, project and data management, and sample logistics on a global basis. They will leverage Cancer Genetics' expertise in genomics and other technologies focused on cancer and Icon's know-how in strategic development and management, as well as the analysis of lab data from large-scale clinical programs. 

The partnership is focused on providing a "comprehensive, integrated, and efficient solution for laboratory testing for global oncology trials from Phase I through Phase IV," they said in a statement. 

Financial and other terms of the deal were not disclosed. 

"This partnership will satisfy the enormous need among biotech and pharmaceutical companies for more efficient and comprehensive testing solutions by integrating [Cancer Genetics'] specialized, genomic testing [into] Icon's laboratory solutions," Cancer Genetics CEO Panna Sharma said.

Advertisement